How is cerezyme made?

Cerezyme (imiglucerase) is a manufactured replacement enzyme used for Gaucher disease. It’s made using biotechnology, not extracted from human tissue.

In simple terms, how it’s made:

1. Gene engineered into cultured cells: Scientists insert the gene for the therapeutic enzyme (β‑glucocerebrosidase) into a suitable cell line (commonly Chinese hamster ovary [CHO] cells).
2. Cells produce the enzyme: The engineered cells are grown in large bioreactors, where they secrete the enzyme into the culture medium.
3. Purification: The enzyme is then purified through multiple chromatography/filtration steps to remove cell proteins, DNA, and other impurities.
4. Formulation: The purified enzyme is formulated into the final injectable drug (with stabilizers/excipients such as buffers, to maintain stability).
5. Quality control & release: The final product is tested for identity, purity, potency, glycosylation pattern, and other critical quality attributes before being released.

If you want, tell me whether you’re asking about the general process (above) or specifically what cell line/process and what controls are used for Cerezyme vs. similar products like VPRIV (velaglucerase).